Diagnostic imaging services provider RadNet (NASDAQ:RDNT), and iCAD (NASDAQ:ICAD), a provider of AI-powered breast health solutions, announced on Tuesday that they have entered into a definitive ...

iCAD (ICAD) is advancing 5% in early trading despite today’s sharp downturn of the broader market. The company, whose products utilize AI to detect breast cancer, preannounced higher-than-expected ...

ICAD ($ICAD) is expected to release its quarterly earnings data on Wednesday, March 19th after market close, per Finnhub. Analysts are expecting revenue of $4,924,050 ...

icad will be reporting earnings from the most recent quarter on May 15. Wall Street predict expect icad will release losses per share of $0.062. Go here to follow icad stock price in real-time on ...

icad (ICAD) is scheduled to report earnings on March 11, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.

Wall Street expects a year-over-year decline in earnings on lower revenues when Icad (ICAD) reports results for the quarter ended December 2021. While this widely-known consensus outlook is important ...

Icad Inc ICAD shares are trading higher Monday after the company announced a strategic development and commercialization agreement with Alphabet Inc's GOOG Google Health. The agreement will allow ...

NASHUA, N.H., March 02, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (the “Company”, NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today ...